Breaking News, Financial News

Financial Report: Patheon 3Q

Revenues from commercial manufacturing operations were down 2% to $130.2 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 3Q
 3Q Revenues: $163.3 million (-1%) 3Q Loss: $3.0 million (loss of $5.2 million in 3Q09) YTD Revenues: $493.5 million (+3%) YTD Loss: $2.4 million (loss of $4.9 million YTD09) Comments: Revenues from commercial manufacturing operations were down 2% to $130.2 million. North American commercial revenues increased $5.3 million, or 9% due to improved production in PR and favorable foreign exchange. European commercial revenues were down $8.0 million or 11% due to reduced vo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters